Variabilidade morfológica da coleção de germoplasma de batata-doce da Embrapa-Centro Nacional de Pesquisa de Hortaliças

A coleção de germoplasma de batata-doce (Ipomoea batatas L.), mantida pela Embrapa-Centro Nacional de Pesquisa de Hortaliças, foi reunida por meio de expedições de coleta e pela duplicação da coleção anteriormente mantida pela Embrapa-Centro Nacional de Pesquisa de Mandioca e Fruticultura. O objetivo deste trabalho foi descrever e analisar a variabilidade morfológica mantida nessa coleção. Foram avaliados 324 acessos nativos de batata-doce, utilizando-se 25 características morfológicas. Foi possível identificar 256 tipos morfológicos, sendo 223 acessos com morfologia única e 33 grupos de acessos morfologicamente duplicados. Cerca de 20% da coleção consistia de duplicações. Com base na estimativa da diversidade fenotípica mantida na coleção de cada descritor utilizado, considerou-se que a coleção apresenta um nível de polimorfismo alto. Os resultados obtidos foram discutidos em termos de sua utilização na organização da coleção, no planejamento da coleção in vitro dos campos de produção de sementes botânicas e das atividades de caracterização molecular, e no gerenciamento deste recurso genético em âmbito nacional.

Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets.

BACKGROUND: The differentiation of CD8+ T lymphocytes following priming of naïve cells is central in the establishment of the adaptive immune response. Yet, the molecular events underlying this process are not fully understood. MicroRNAs have been recently shown to play a key role in the regulation of haematopoiesis in mouse, but their implication in peripheral lymphocyte differentiation in humans remains largely unknown. METHODS: In order to explore the potential implication of microRNAs in CD8+ T cell differentiation in humans, microRNA expression profiles were analysed using microarrays and quantitative PCR in several human CD8+ T cell subsets defining the major steps of the T cell differentiation pathway. RESULTS: We found expression of a limited set of microRNAs, including the miR-17~92 cluster. Moreover, we reveal the existence of differentiation-associated regulation of specific microRNAs. When compared to naive cells, miR-21 and miR-155 were indeed found upregulated upon differentiation to effector cells, while expression of the miR-17~92 cluster tended to concomitantly decrease. CONCLUSIONS: This study establishes for the first time in a large panel of individuals the existence of differentiation associated regulation of microRNA expression in human CD8+ T lymphocytes in vivo, which is likely to impact on specific cellular functions.

Defining the RNA polymerase III transcriptome: Genome-wide localization of the RNA polymerase III transcription machinery in human cells.

Our view of the RNA polymerase III (Pol III) transcription machinery in mammalian cells arises mostly from studies of the RN5S (5S) gene, the Ad2 VAI gene, and the RNU6 (U6) gene, as paradigms for genes with type 1, 2, and 3 promoters. Recruitment of Pol III onto these genes requires prior binding of well-characterized transcription factors. Technical limitations in dealing with repeated genomic units, typically found at mammalian Pol III genes, have so far hampered genome-wide studies of the Pol III transcription machinery and transcriptome. We have localized, genome-wide, Pol III and some of its transcription factors. Our results reveal broad usage of the known Pol III transcription machinery and define a minimal Pol III transcriptome in dividing IMR90hTert fibroblasts. This transcriptome consists of some 500 actively transcribed genes including a few dozen candidate novel genes, of which we confirmed nine as Pol III transcription units by additional methods. It does not contain any of the microRNA genes previously described as transcribed by Pol III, but reveals two other microRNA genes, MIR886 (hsa-mir-886) and MIR1975 (RNY5, hY5, hsa-mir-1975), which are genuine Pol III transcription units.

09011-008 Walnut Creek Final Report

Walnut Creek is a Class B warm water stream located in northern Poweshiek County. The creek is sixteen miles in length with 26,223 acres of watershed area. Walnut Creek is listed on the 2008 impaired waters list as biologically impaired. Based on results of biological monitoring, no specific causes of the impairment have been identified. This watershed is of particular significance to the Poweshiek SWCD and the state of Iowa because water quality protection efforts can be implemented that will address the impairment. The Poweshiek SWCD received a watershed development grant in 2005, to complete a watershed assessment for the Walnut Creek Watershed. The results of the assessments showed an estimated 23,224 tons of sediment are delivered annually to Walnut Creek, and, about 34% of land in the watershed is delivering nearly 66% of the sediment. Therefore, the acres with more than 1 ton/ac/yr sediment delivery have been prioritized. In Jan. 2008, an implementation grant began. The 1st year’s EQIP matching funds were obligated by July 2008. Specific objectives are to: 1) Reduce sediment delivery by 3,205 tons, by installing conservation practices on the sediment delivery areas of more that 1 ton/ac/yr, and, 2) Develop an information and education program for landowners. The District has prioritized the Walnut Creek watershed for 50% EQIP funding to be combined with 25% WSPF funds. This application is for additional practice funds, utilized as 50% cost-share, to be used with 25% WSPF funds, for eligible soil loss projects (>1 ton/ac), when EQIP funds are not available.

Iowa Department of Transportation Major Items - Preliminary Quantity Report, December 16, 2014; With Addendums

Weekly letting report.

Proteasomal cleavage does not determine immunogenicity of gp100-derived peptides gp100 209-217 and gp100 209-217T210M.

Immune responses against tumor-associated antigens rely on efficient epitope presentation. The melanoma-associated antigen (Ag) gp100 contains HLA-A*0201 ligands that are characterized by low to medium binding affinity, among which gp100(209-217) is the most prominent (Kawakami et al., J Immunol 154:3961-3968, 1995). While this epitope is a natural T-cell target, it primes with low-efficiency T-cell responses during immunization. A modified gp100 epitope, gp100(209-217T210M), that contains a Thr to Met substitution at position 2 of the antigenic nonamer is characterized by high binding affinity for HLA-A*0201 and elicits strong and clinically effective T-cell responses. This higher affinity is believed to represent the sole reason for enhanced immunogenicity. Contrasting with this observation is the unpredictable relationship between affinity and immunogenicity observed in other antigen systems. In addition, we noted a striking difference between the capability of endogenously processed gp100(209-217) and gp100(209-217T210M) to induce T-cell responses in an in vitro model. Therefore, we questioned whether factors other than HLA-affinity might play a role in determining the immunogenicity of these epitopes. In the present study, we evaluated the in vitro proteasomal cleavages of 23meric precursor peptides encompassing the native sequence (gp100(201-223)) or the modified sequence (gp100(201-223T210M)). Here we show that the standard proteasome liberates the C-termini of both antigenic peptides but not the N-termini. Quantitative analysis of the digestion products revealed that more of the fragments displaying the final C-termini were produced from the wild-type precursor. However, a stronger TCR engagement was observed when fractions of digested gp100(201-223T210M) were used to activate an HLA-A*0201-expressing target T-cell clone. This difference was also found using separately produced, synthetic nonamers. In conclusion, the high binding affinity of gp100(209-217T210M) seems to compensate for possible differences in proteasomal cleavage at the biological level. Since the final antigenic nonamer is not directly produced by the proteasome, additional further factors may influence the antigenic peptide availability, such as post-proteasomal processing and intracellular peptide transport.

Venture capital financing : screening and contracting under assymetric information

Structure of the Thesis This thesis consists of 5 sections. Section 1 starts with the problem definition and the presentation of the objectives of this thesis. Section 2 introduces a presentation of the theoretical foundations of Venture financing and a review of the main theories developed on Venture investing. It includes a taxonomy of contracting clauses relevant in venture contracting, the conflicts they address, and presents some general observations on contractual clauses. Section 3 presents the research findings on the analysis of a European VC's deal flow and investment screening linked to the prevailing market conditions. Section 4 focuses an empirical study of a European VC's investment process, the criteria it uses to make its investments. It presents empirical findings on the investment criteria over time, business cycles, and investment types. It also links these criteria to the VC's subsequent performance. Finally, section 5 presents an empirical research on the comparison of the legal contracts signed between European and United States Venture Capitalists and the companies they finance. This research highlights some of the contracting practices in Europe and the United States.

Advances in paediatric interventional cardiology since 2000.

Interventional paediatric and congenital cardiology is expanding at a rapid pace. Validated techniques (such as aortic or pulmonary valve dilatations and occlusion of persistent ductus arteriosus and atrial septal defects) are improving thanks to the use of smaller introducers and sheaths, low-profile balloons and novel devices. Moreover, catheter-based interventions have emerged as an attractive alternative to surgery in other fields: pulmonary valve replacement, balloon and stent implantation for native and recurrent coarctation, and percutaneous closure of ventricular septal defects. On the other hand, percutaneous interventions in the paediatric population may be limited by patient size or the anatomy of the defect. Hybrid approaches involving both cardiac interventionists and surgeons are being developed to overcome these limitations. Based on a better understanding of cardiac development, fetal cardiac interventions are being attempted in order to alter the history of severe obstructive lesions. Finally, some interventional procedures still carry a low success rate-for example, pulmonary vein stenosis, even with the use of conventional stents. Biodegradable stents and devices are being developed and may find an application in this setting as well as in others. The purpose of this review is to highlight the advances in paediatric interventional cardiology since the beginning of the third millennium.

New strategies in the modulation of fatty acid oxidation as a treatment for obesity

Strategies that enhance fat degradation or reduce caloricfood intake could be considered therapeutic interventions to reduce notonly obesity, but also its associated disorders. The enzyme carnitinepalmitoyltransferase 1 (CPT1) is the critical rate-determining regulatorof fatty acid oxidation (FAO) and might play a key role in increasingenergy expenditure and controlling food intake. Our group has shownthat mice overexpressing CPT1 in liver are protected from weight gain,the development of obesity and insulin resistance. Regarding foodintake control, we observed that the pharmacological inhibition ofCPT1 in rat hypothalamus decreased food intake and body weight.This suggests that modulation of CPT1 activity and the oxidation offatty acids in various tissues can be crucial for the potential treatmentof obesity and associated pathologies.

Hémorragie intra-alvéolaire [Alveolar hemorrhage].

Diffuse alveolar hemorrhage (DAH) is defined by the presence of red blood cells originating from the lung capillaries or venules within the alveoli. The diagnosis is established on clinical features, radiological pattern, and especially bronchoalveolar lavage. Diffuse alveolar hemorrhage may have many immune or non-immune causes. Immune causes of DAH include vasculitides, connective tissue diseases, especially systemic lupus erythematosus, and antiglomerular basement membrane antibody disease (Goodpasture's syndrome). Treatment is both supportive and causal, often based on high dose corticosteroids and immunosuppressive therapy (especially intravenous cyclophosphamide). Plasma exchanges are performed in antiglomerular basement membrane antibody disease and systemic lupus erythematosus, and are considered in systemic vasculitis. Non-immune causes of DAH mainly include heart diseases, coagulation disorders, infections, drug toxicities and idiopathic DAH. Treatment of non-immune DAH is that of its cause. Whatever the cause, DAH is an emergency requiring prompt assessment and early treatment.

La implementación y transferibilidad del ABP

El ABP es una metodología centrada en el estudiante, protagonista de un proceso de enseñanzaaprendizaje, que se realiza en el contexto de equipos de trabajo colaborativos y autogestionados. Se trata de una educación competencial que cobra nuevo sentido con los actuales planes de estudios

Periodismo económico en España

El present estudi aporta una visió global del periodisme econòmic a Espanya des de tres òptiques interrelacionades. La primera és un repàs de l'evolució històrica del sector, complementada amb una descripció de la importància econòmica del mateix, per a finalment, reflexionar sobre els reptes que es plantegen en els propers anys, a un sector durament castigat per la crisi actual. La síntesi del treball es pot veure reflectida mitjançant una representació gràfica dels principals grups mediàtics actuals, que són la viva imatge, tant de la història passada, com els responsables d'escriure el futur del sector periodístic econòmic.